Search research articles
Contact Us
Filters
Showing results (681-690 of 799) with videos related to
Page
of 80
Sort By:
Cancer Immunology Research
|
April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome
Bridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Paul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Human Molecular Genetics
|
November 8, 2014
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Jodie N Painter, Tracy A O'Mara, Jyotsna Batra, et al.
Breast (Edinburgh, Scotland)
|
November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
Amandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Human Molecular Genetics
|
August 2, 2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Yi Lu, Gabriel Cuellar-Partida, Jodie N Painter, et al.
American Journal of Human Genetics
|
September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Maya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
International Journal of Epidemiology
|
July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Suzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Page
of 80
Search research articles
Search
Showing results (681-690 of 799) with videos related to
Sort By:
Page
of 80
Cancer Immunology Research
|
April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome
Bridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Paul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Human Molecular Genetics
|
November 8, 2014
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Jodie N Painter, Tracy A O'Mara, Jyotsna Batra, et al.
Breast (Edinburgh, Scotland)
|
November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
Amandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Human Molecular Genetics
|
August 2, 2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Yi Lu, Gabriel Cuellar-Partida, Jodie N Painter, et al.
American Journal of Human Genetics
|
September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Maya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
International Journal of Epidemiology
|
July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Suzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Page
of 80